Taysha Gene Therapies, Inc. - COM SHS (TSHA)

Q3 2020 13F Holders as of 9/30/2020

Type / Class
Equity / COM SHS
Number of holders
46
Total Shares
16.6M
Shares change
+16.6M
Total reported value, excl. options
$367M
Value change
+$367M
Put/Call ratio
0
Number of buys
46
Number of sells
0
Price
$22.40
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.